Fiscal year ending 2017. Filed on November 1, 2018.
40 Wall Street 24th Floor
Gummadidala Sangareddy
New York, New York 10005
Global Alliance for Tb Drug Development Inc. (EIN: 13-4128413), also known as Tb Alliance, has filed an IRS Form 990 since fiscal year 2017. In its fiscal year 2017 IRS Form 990 filing, Global Alliance for Tb Drug Development Inc., a 501(c)(3) charitable organization, reported compensation for 11 out of 50 total employees. Among the employees shown here, the average compensation is $442,050. The highest compensated employee at Global Alliance for Tb Drug Development Inc. is Dr Melvin Spigelman with fiscal year 2017 compensation of $823,781.
Revenue
Expenses
Employee compensation
TB ALLIANCE IS A NOT-FOR-PROFIT ORGANIZATION DEDICATED TO THE DISCOVERY, DEVELOPMENT AND DELIVERY OF BETTER, FASTER-ACTING AND AFFORDABLE TUBERCULOSIS DRUGS THAT ARE AVAILABLE TO THOSE WHO NEED THEM.
Be the first to know when new IRS Form 990 data is published for this organization.